- Home
- ASRT vs ABP Comparison
ASRT vs ABP Comparison
Compare ASRT & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- ABP
- Stock Information
- Founded
- ASRT 1995
- ABP 2004
- Country
- ASRT United States
- ABP United States
- Employees
- ASRT N/A
- ABP N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- ABP Biotechnology: Pharmaceutical Preparations
- Sector
- ASRT Health Care
- ABP Health Care
- Exchange
- ASRT Nasdaq
- ABP Nasdaq
- Market Cap
- ASRT 78.3M
- ABP 76.2M
- IPO Year
- ASRT 1997
- ABP N/A
- Fundamental
- Price
- ASRT $0.81
- ABP $0.84
- Analyst Decision
- ASRT Strong Buy
- ABP
- Analyst Count
- ASRT 4
- ABP 0
- Target Price
- ASRT $3.19
- ABP N/A
- AVG Volume (30 Days)
- ASRT 320.8K
- ABP 39.1K
- Earning Date
- ASRT 03-10-2025
- ABP 03-07-2025
- Dividend Yield
- ASRT N/A
- ABP N/A
- EPS Growth
- ASRT N/A
- ABP N/A
- EPS
- ASRT N/A
- ABP N/A
- Revenue
- ASRT $125,763,000.00
- ABP $230,000.00
- Revenue This Year
- ASRT N/A
- ABP N/A
- Revenue Next Year
- ASRT $1.84
- ABP N/A
- P/E Ratio
- ASRT N/A
- ABP N/A
- Revenue Growth
- ASRT N/A
- ABP N/A
- 52 Week Low
- ASRT $0.73
- ABP $0.80
- 52 Week High
- ASRT $1.80
- ABP $13.00
- Technical
- Relative Strength Index (RSI)
- ASRT 45.61
- ABP N/A
- Support Level
- ASRT $0.78
- ABP N/A
- Resistance Level
- ASRT $0.88
- ABP N/A
- Average True Range (ATR)
- ASRT 0.03
- ABP 0.00
- MACD
- ASRT 0.00
- ABP 0.00
- Stochastic Oscillator
- ASRT 32.80
- ABP 0.00
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.